The genesis of tyrosine phosphorylation

Cold Spring Harbor Perspectives in Biology

Volumn 6, Issue 5, 2014, Pages

  Hunter, Tony ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; TYROSINE;

ANIMAL; BIOLOGY; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN ENGINEERING;

ANIMALS; COMPUTATIONAL BIOLOGY; HUMANS; PHOSPHORYLATION; PROTEIN ENGINEERING; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-TYROSINE KINASES; TYROSINE;

EID: 84899749070     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a020644     Document Type: Article

References (64)

1. Allen J. J, Li M, Brinkworth CS, Paulson JL, Wang D, Hubner A, Chou WH, Davis RJ, Burlingame AL, Messing RO, et al. 2007. A semisynthetic epitope for kinase substrates. Nat Methods 4: 511-516.
2. Alonso A., Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. 2004. Protein tyrosine phosphatases in the human genome. Cell 117: 699-711.
3. Arkhipov A., Shan Y, Das R, Endres NF, Eastwood MP, Wemmer D. E, Kuriyan J, Shaw DE. 2013. Architecture and membrane interactions of the EGF receptor. Cell 152: 557-569.
4. Beltrao P., AlbaneseV, Kenner LR, Swaney DL, Burlingame A, Villen J., LimWA, Fraser JS, Frydman J, Krogan NJ. 2012. Systematic functional prioritization of protein posttranslational modifications. Cell 150: 413-425.
5. Bishop A. C, Ubersax JA, Petsch DT, Matheos DP, Gray NS, Blethrow J., Shimizu E, Tsien JZ, Schultz PG, Rose MD, et al. 2000. A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407: 395-401.
6. Burnett G., Kennedy EP. 1954. The enzymatic phosphorylation of proteins. J Biol Chem 211: 969-980.
7. Carpenter G., King L Jr, Cohen S. 1978. Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature 276: 409-410.
8. Carpenter G., King L Jr, Cohen S. 1979. Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor. J Biol Chem 254: 4884-4891.
9. Chinkers M., Cohen S. 1981. Purified EGF receptor-kinase interacts specifically with antibodies to Rous sarcoma virus transforming protein. Nature 290: 516-519.
10. Collett M. S, Erikson E, Erikson RL. 1979. Structural analysis of the avian sarcoma virus transforming protein: Sites of phosphorylation. J Virol 29: 770-781.
11. Cooper J. A, Hunter T. 1981. Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus. J Cell Biol 91: 878-883.
12. Downward J., Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD. 1984. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307: 521-527.
13. Eckhart W., Hutchinson MA, Hunter T. 1979. An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates. Cell 18: 925-933.
14. Endres N. F, Das R, Smith AW, Arkhipov A, Kovacs E, Huang Y, Pelton JG, Shan Y, Shaw DE, Wemmer DE, et al. 2013. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 152: 543-556.
15. Filippakopoulos P., Kofler M, Hantschel O, Gish GD, Grebien F, Salah E, Neudecker P, Kay LE, Turk BE, Superti-Furga G., et al. 2008. Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell 134: 793-803.
16. Frackelton A. R Jr, Ross AH, Eisen HN. 1983. Characterization and use of monoclonal antibodies for isolation of phosphotyrosyl proteins from retrovirus-transformed cells and growth factor-stimulated cells. Mol Cell Biol 3: 1343-1352.
17. Gao X., Wang H, Yang JJ, Liu X, Liu ZR. 2012. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 45: 598-609.
18. Grangeasse C., Nessler S, Mijakovic I. 2012. Bacterial tyrosine kinases: Evolution, biological function and structural insights. Philos Trans R Soc Lond B Biol Sci 367: 2640-2655.
19. Hallberg B., Palmer RH. 2010. Crizotinib-Latest champion in the cancer wars? N Engl J Med 363: 1760-1762.
20. Hidaka H., Inagaki M, Kawamoto S, Sasaki Y. 1984. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23: 5036-5041.
21. Holt L. J, Tuch BB, Villen J, Johnson AD, Gygi SP, Morgan DO. 2009. Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution. Science 325: 1682-1686.
22. Hubbard S. R, Wei L, Ellis L, HendricksonWA. 1994. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372: 746-754.
23. Hunter T. 2007. Treatment for chronic myelogenous leukemia: The long road to imatinib. J Clin Invest 117: 2036-2043.
24. Hunter T., Cooper JA. 1981. Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells. Cell 24: 741-752.
25. Hunter T., Sefton BM. 1980. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci 77: 1311-1315.
26. Kannan N., Taylor SS, Zhai Y, Venter JC, Manning G. 2007. Structural and functional diversity of the microbial kinome. PLoS Biol 5: e17.
27. Kleiman L. B, Maiwald T, Conzelmann H, LauffenburgerDA, Sorger P.K. 2011. Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding. Mol Cell 43: 723-737.
28. Lacey V. K, Parrish AR, Han S, Shen Z, Briggs SP, Ma Y, Wang L. 2011. A fluorescent reporter of the phosphorylation status of the substrate protein STAT3. Angew Chem Int Ed Engl 50: 8692-8696.
29. Lemmon M. A, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell 141: 1117-1134.
30. Levene P. A, Shcormuller A. 1933. The synthesis of tyrosinephosphoric acid. J Biol Chem 100: 583-587.
31. Lillemeier B. F, Mortelmaier MA, Forstner MB, Huppa JB, Groves J. T, Davis MM. 2010. TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation. Nat Immunol 11: 90-96.
32. Lin C. R, ChenWS, KruigerW, Stolarsky LS, WeberW, Evans RM, Verma IM, Gill GN, Rosenfeld MG. 1984. Expression cloning of human EGF receptor complementary DNA: Gene amplification and three related messenger RNA products in A431 cells. Science 224: 843-848.
33. Linding R., Jensen LJ, Pasculescu A, Olhovsky M, Colwill K, Bork P., Yaffe MB, Pawson T. 2008. NetworKIN:A resource for exploring cellular phosphorylation networks. Nucleic Acids Res 36: D695-D699.
34. Machida K., Thompson CM, Dierck K, Jablonowski K, Karkkainen S, Liu B, Zhang H, Nash PD, Newman DK, Nollau P, et al. 2007. High-throughput phosphotyrosine profiling using SH2 domains. Mol Cell 26: 899-915.
35. MacKeigan JP, Murphy LO, Blenis J. 2005. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 7: 591-600.
36. Maher P. A, Pasquale EB, Wang JY, Singer SJ. 1985. Phosphotyrosine-containing proteins are concentrated in focal adhesions and intercellular junctions in normal cells. Proc Natl Acad Sci 82: 6576-6580.
37. Manning G., Whyte DB, Martinez R, Hunter T, Sudarsanam S. 2002. The protein kinase complement of the human genome. Science 298: 1912-1934.
38. Manning G., Young SL, MillerWT, Zhai Y. 2008. The protist, Monosiga brevicollis, has a tyrosine kinase signaling network more elaborate and diverse than found in any known metazoan. Proc Natl Acad Sci 105: 9674-9679.
39. Marchisio P. C, Di Renzo MF, Comoglio PM. 1984. Immunofluorescence localization of phosphotyrosine containing proteins in RSV-transformed mouse fibroblasts. Exp Cell Res 154: 112-124.
40. Mikhailik A., Ford B, Keller J, Chen Y, Nassar N, Carpino N. 2007. A phosphatase activity of Sts-1 contributes to the suppression of TCR signaling. Mol Cell 27: 486-497.
41. Obenauer J. C, Cantley LC, Yaffe MB. 2003. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 31: 3635-3641.
42. Okada H., Uezu A, Mason FM, Soderblom EJ, Moseley MA 3rd, Soderling SH. 2011. SH3 domain-based phototrapping in living cells reveals Rho family GAP signaling complexes. Sci Signal 4: prs13.
43. Pincus D., Letunic I, Bork P, LimWA. 2008. Evolution of the phospho-tyrosine signaling machinery in premetazoan lineages. Proc Natl Acad Sci 105: 9680-9684.
44. Radke K., Gilmore T, Martin GS. 1980. Transformation by Rous sarcoma virus: A cellular substrate for transformation-specific protein phosphorylation contains phosphotyrosine. Cell 21: 821-828.
45. Rikova K., Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J., Lee K, Reeves C, Li Y, et al. 2007. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131: 1190-1203.
46. Ross A. H, Baltimore D, Eisen HN. 1981. Phosphotyrosinecontaining proteins isolated by affinity chromatography with antibodies to a synthetic hapten. Nature 294: 654-656.
47. Rush J., Moritz A, Lee KA, Guo A, Goss VL, Spek EJ, Zhang H, Zha XM, Polakiewicz RD, Comb MJ. 2005. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23: 94-101.
48. Sefton B. M, Hunter T, Beemon K, EckhartW. 1980. Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus. Cell 20: 807-816.
49. Shah K., Liu Y, Deirmengian C, Shokat KM. 1997. Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates. Proc Natl Acad Sci 94: 3565-3570.
50. Shapiro B. M, Stadtman ER. 1968. 50-Adenylyl-O-tyrosine. The novel phosphodiester residue of adenylylated glutamine synthetase from Escherichia coli. J Biol Chem 243: 3769-3771.
51. Sherman E., Barr V, Manley S, Patterson G, Balagopalan L, Akpan I., Regan CK, Merrill RK, Sommers CL, Lippincott-Schwartz J., et al. 2011. Functional nanoscale organization of signaling molecules downstream of the T cell antigen receptor. Immunity 35: 705-720.
52. Songyang Z., Blechner S, Hoagland N, Hoekstra MF, Piwnica-Worms H., Cantley LC. 1994. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr Biol 4: 973-982.
53. Statsuk A. V, Maly DJ, Seeliger MA, Fabian MA, Biggs WH 3rd, Lockhart DJ, Zarrinkar PP, Kuriyan J, Shokat KM. 2008. Tuning a three-component reaction for trapping kinase substrate complexes. J Am Chem Soc 130: 17568-17574.
54. Taylor S. S, Radzio-Andzelm E, Hunter T. 1995. How do protein kinases discriminate between serine/threonine and tyrosine? Structural insights from the insulin receptor protein-tyrosine kinase. FASEB J 9: 1255-1266.
55. Ting A. Y, Kain KH, Klemke RL, Tsien RY. 2001. Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells. Proc Natl Acad Sci 98: 15003-15008.
56. Tinti M., Kiemer L, Costa S, Miller ML, Sacco F, Olsen JV, Carducci M., Paoluzi S, Langone F, Workman CT, et al. 2013. The SH2 domain interaction landscape. Cell Rep 3: 1293-1305.
57. Uezu A., Okada H, Murakoshi H, del Vescovo CD, Yasuda R, Diviani D., Soderling SH. 2012. Modified SH2 domain to phototrap and identify phosphotyrosine proteins from subcellular sites within cells. Proc Natl Acad Sci 109: E2929-E2938.
58. Ushiro H., Cohen S. 1980. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem 255: 8363-8365.
59. Waksman G., Kominos D, Robertson SC, Pant N, Baltimore D, Birge RB, Cowburn D, Hanafusa H, Mayer BJ, Overduin M, et al. 1992. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358: 646-653.
60. Worby C. A, Mattoo S, Kruger RP, Corbeil LB, Koller A, Mendez J. C, Zekarias B, Lazar C, Dixon JE. 2009. The fic domain: Regulation of cell signaling by adenylylation. Mol Cell 34: 93-103.
61. Yarden Y., Schlessinger J. 1987. Self-phosphorylation of epidermal growth factor receptor: Evidence for a model of intermolecular allosteric activation. Biochemistry 26: 1434-1442.
62. Zhang J., Ma Y, Taylor SS, Tsien RY. 2001. Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering. Proc Natl Acad Sci 98: 14997-15002.
63. Zhang X., Gureasko J, Shen K, Cole PA, Kuriyan J. 2006. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125: 1137-1149.
64. Zhou S., Shoelson SE, Chaudhuri M, Gish GD, Pawson T, HaserWG, King F, Roberts T, Ratnofsky S, Lechleider RJ, et al. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767-778.